Nuon Therapeutics, Inc. is a clinical stage biopharmaceutical company developing medicines to treat autoimmune and rheumatic disease.
In its two most advanced programs, Nuon Therapeutics, Inc. is evaluating compounds in clinical trials for chronic hyperuricemia in patients with gout and rheumatoid arthritis.
Nuon Therapeutics, Inc. is committed to advancing innovative therapies through clinical development and commercialization.
Nuon Therapeutics Announces Positive Topline Results From a Phase 2a Study in Hyperuricemia